Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.

Sarantopoulos J, Mita MM, Birrer MJ, Cranmer LD, Campos LT, Zhang X, Bristow P, Kaito H, Strout V, Camacho LH.

Target Oncol. 2016 Jun;11(3):317-27. doi: 10.1007/s11523-015-0394-5.

PMID:
26507836
3.

Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibody.

Kasai N, Yoshikawa Y, Enokizono J.

MAbs. 2014;6(5):1220-8. doi: 10.4161/mabs.29792. Epub 2014 Nov 1.

Supplemental Content

Loading ...
Support Center